Does seizure propagate within or across intrinsic brain networks? An intracranial EEG study

BACKGROUND

Understanding the spatiotemporal propagation profiles of seizures is crucial for the preoperative assessment of epilepsy patients. The present study aimed to investigate whether seizures exhibit propagation patterns that align with intrinsic networks (INs).

METHODS

A quantitative analysis was conducted to examine ictal fast activity (IFA). The Epileptogenicity Index (EI) was employed to assess the epileptogenicity, spectral features, and temporal characteristics of IFA. Intra-network and inter-network comparisons were made regarding the IFA-related metrics. Additionally, the metrics were correlated with Euclidean distance. Network connection maps were generated to visualize seizures originating from different INs, allowing for comparisons between distinct groups.

RESULTS

Data for 81 seizures in 43 subjects were captured using stereoelectroencephalography implantation. Three metrics were compared: EI, time involvement (TI), and energy ratio index (ERI). Intra-network channels exhibited higher EI, earlier involvement of IFA, and stronger high-frequency energy. These findings were further validated through subgroup analyses stratified by neuropathology, seizure type, and seizure origination lobe. Correlation analyses revealed a negative association between distance and both EI and ERI, while distance exhibited a positive correlation with TI. Seizures originating from different INs exhibited varying propagation characteristics.

CONCLUSIONS

The study findings highlight the dominant role of intra-network dynamics over inter-network during seizure propagation. These results contribute to our understanding of seizure dynamics and their relationship with INs.

Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression

Late-life depression is characterized by both lower mood and poor cognitive performance, symptoms that often do not fully respond to current antidepressant medications. Nicotinic acetylcholine receptor (nAChR) agonists such as nicotine may serve as a novel therapeutic approach for this population. Both preclinical and preliminary clinical studies suggest that nAChR agonists can improve depressive behavior in animal models and improve mood in depressed individuals. Substantial literature also supports that nAChR agonists benefit cognitive performance, particularly in older populations. These potential benefits may be mediated by the effects of nAChR stimulation on neural network function and connectivity. Functional neuroimaging studies detail effects of nAChR agonists on the default mode network, central-executive network, and salience network that may oppose or reverse network changes seen in depression. We propose that, given the existent literature and the clinical presentation of late-life depression, nicotine or other nAChR agonists may have unique therapeutic benefits in this population and that clinical trials examining nicotine effects on mood, cognition, and network dynamics in late-life depression are justified.